XML 89 R36.htm IDEA: XBRL DOCUMENT
v3.19.3.a.u2

SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS | 12 Months Ended
--- | ---
Dec. 31, 2019
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract] |
SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS |
|  |  |  | Additions |  |  |  |
Description |  | Balance at Beginning of Period |  | Charged to Earnings |  | Transferred from Other Accounts (1) |  | Deductions (2) |  | Balance at End of Period
|  | (In thousands)
2019 |  |  |  |  |  |  |  |  |  |
Accounts receivable allowance |  | $ | 17,182 |  |  | 23,003 |  |  | — |  |  | 17,424 |  |  | $ | 22,761 |
Self-insurance accruals (3) |  | $ | 357,526 |  |  | 436,148 |  |  | 86,832 |  |  | 469,521 |  |  | $ | 410,985 |
Valuation allowance on deferred tax assets |  | $ | 16,186 |  |  | 1,906 |  |  | — |  |  | 515 |  |  | $ | 17,577 |
2018 |  |  |  |  |  |  |  |  |  |
Accounts receivable allowance |  | $ | 13,847 |  |  | 10,890 |  |  | — |  |  | 7,555 |  |  | $ | 17,182 |
Self-insurance accruals (3) |  | $ | 348,612 |  |  | 359,528 |  |  | 82,904 |  |  | 433,518 |  |  | $ | 357,526 |
Valuation allowance on deferred tax assets |  | $ | 18,667 |  |  | (534 | ) |  | — |  |  | 1,947 |  |  | $ | 16,186 |
2017 |  |  |  |  |  |  |  |  |  |
Accounts receivable allowance |  | $ | 14,915 |  |  | 12,335 |  |  | — |  |  | 13,403 |  |  | $ | 13,847 |
Self-insurance accruals (3) |  | $ | 336,901 |  |  | 327,306 |  |  | 74,153 |  |  | 389,748 |  |  | $ | 348,612 |
Valuation allowance on deferred tax assets |  | $ | 16,387 |  |  | 2,213 |  |  | — |  |  | (67 | ) |  | $ | 18,667 |
______________
(1) | Transferred from other accounts includes employee contributions made to the medical and dental self-insurance plans.
(2) | Deductions represent write-offs, lease termination payments, insurance claim payments during the period and net foreign currency translation adjustments.
(3) Self-insurance accruals include vehicle liability, workers’ compensation, property damage, cargo and medical and dental, which comprise our self-insurance programs. Amounts charged to earnings include developments in prior years' selected loss development factors, which charged earnings by $18 million in 2019 and $1 million in 2018 and benefited earnings by $9 million in 2017.

X
- Definition The entire disclosure for valuation and qualifying accounts and reserves. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 12 -Subsection 09 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 4 -Subparagraph (SX 210.12-09) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e24092-122690 + Details
Name: | srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock
Namespace Prefix: | srt_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | srt_ValuationAndQualifyingAccountsAbstract
Namespace Prefix: | srt_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration